HAVN Life Sciences  is a biotechnology company focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. They went public in September 2020.

“We believe in people and their potential. We envision a world where everyone is operating at peak mental performance, free from the stresses and imbalances that hold us back.”

We are focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing innovative mental health treatment to support brain health and enhance the capabilities of the mind.

With an extensive team of industry leaders with 20+ years of experience in this space, HAVN Life is formulating the next generation of medicine using psychedelic compounds. “

Recent News

Get the Havn Life
Investor’s Kit now.


Market Cap